Skip to main content

Advertisement

Log in

Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis

  • Review Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

The congenital dyserythropoietic anemias (CDAs) comprise a group of rare hereditary disorders of erythropoiesis, characterized by ineffective erythropoiesis as the predominant mechanism of anemia and by distinct morphological abnormalities of the majority of erythroblasts in the bone marrow. The classification in three types as proposed in 1968 is still valid, but there is genetic heterogeneity within each type, and there are additional variants of unknown genetic basis. CDA II is the most frequent, and the nonfamilial type of CDA III the rarest group. The genes of CDA II and CDA III were mapped to chromosome 20 and 15, respectively, and the gene of CDA I on 15q was recently cloned. Therapeutic decision making requires definition of the type, an estimate of individual severity, and presence of or risk for complications. Therapeutic measures include interferon-α for CDA I, splenectomy for CDA II, and iron depletion for all individuals at risk for secondary hemochromatosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. For microphotographs see http://www.bone-marrow-failure-syndromes.de.

References

  1. Adams CD, Kessler JF (1991) Circulating nucleated red blood cells following splenectomy in a patient with congenital dyserythropoietic anemia. Am J Hematol 38:120–123

    CAS  PubMed  Google Scholar 

  2. Alloisio N, Texier P, Denoroy L, Berger C, Miraglia del Giudice E, Perrotta S, Iolascon A, Gilsanz F, Berger G, Guichard J (1996) The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum. Blood 87:4433–4439

    CAS  PubMed  Google Scholar 

  3. Anselstetter V, Horstmann K, Heimpel H (1977) Congenital dyserythropoetic anaemia, types I and II: aberrant pattern of erythrocyte membrane proteins in CDA II, as revealed by two-dimensional polyacrylamide gel electrophoresis. Br J Haematol 35:209–215

    CAS  PubMed  Google Scholar 

  4. Ayas M, al Jefri A, Baothman A, al Mahr M, Mustafa MM, Khalil S, Karaoui M, Solh H (2002) Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogeneic stem cell transplantation. Bone Marrow Transplant 29:681–682

    Article  CAS  PubMed  Google Scholar 

  5. Barosi G, Cazzola M, Stefannelli M, Ascari E (1979) Studies of ineffective erythropoiesis and peripheral haemolysis in congenital dyserythropoietic anaemia type II. Br J Haematol 43:243–250

    CAS  PubMed  Google Scholar 

  6. Benjamin JT, Rosse WF, Dalldorf FG, Mc Millan CW (1975) Congenital dyserythropoetic anemia—type IV. J Pediatr 87:210–216

    CAS  PubMed  Google Scholar 

  7. Bergström I, Jacobsson L (1962) Hereditary benign erythroreticulosis. Blood 19:296–303

    PubMed  Google Scholar 

  8. Bethlenfalvay NC, Hadnagy GS, Heimpel H (1985) Unclassified type of congenital dyserythropoietic anemia (CDA) with prominent peripheral erythoblastosis. Br J Haematol 60:541–550

    CAS  PubMed  Google Scholar 

  9. Bethlenfalvay NC, Phaure TAJ, Phlyliky RL, Bowman RP (1986) Nuclear bridging of erythroblasts in acquired dyserythropoesis: an early and transient preleukemic marker. Am J Hematol 21:315–322

    CAS  PubMed  Google Scholar 

  10. Bird AR, Karabus CD, Hartley PS (1985) Type IV congenital dyserythropoietic anemia with unusual response to splenectomy. Am J Pediatr Hematol Oncol 7:196–199

    CAS  PubMed  Google Scholar 

  11. Boogaerts MA, Verwilghen RL (1982) Variants of congenital dyserythropoietic anaemia: an update. Haematologica (Budapest) 15:211–219

    CAS  Google Scholar 

  12. Breton-Gorius J, Daniel M, Clauvel JP, Dreyfus B (1973) Anomalies ultrastructurales des érythroblastes et des érythrocytes dans six cas de dysérythropoièse congénitale. Nouv Rev Fr Hematol 13:23–50

    CAS  PubMed  Google Scholar 

  13. Byrnes RK, Dhru R, Brady AM, Galen WP, Hopper B (1980) Congenital dyserythropoietic anemia in treated Hodgkin’s disease. Hum Pathol 11:485–486

    CAS  PubMed  Google Scholar 

  14. Carter C, Darbyshire PJ, Wickramasinghe SN (1989) A congenital dyserythropoietic anaemia variant presenting as hydrops foetalis. Br J Haematol 72:289–290

    CAS  PubMed  Google Scholar 

  15. Cazzola M, Barosi G, Bergamaschi G, Dezza L, Palestra P, Polino G, Ramella S, Spriano P, Ascari E (1983) Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol 54:649–654

    CAS  PubMed  Google Scholar 

  16. Cazzola M, Beguin Y, Bergamaschi G, Guarnone R, Cerani P, Barella S, Cao A, Galanello R (1999) Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol 106:752–755

    Article  CAS  PubMed  Google Scholar 

  17. Chrobak L, Spacek J (1997) Favorable effect of splenectomy on anemia in 3 siblings with type II congenital dyserythropoietic anemia (HEMPAS). Ultrastructural changes in erythrocytes after splenectomy. Vnitr Lek 43:635–638

    CAS  PubMed  Google Scholar 

  18. Clauvel JP, Cosson A, Breton-Gorius J, Flandrin G, Faille A, Bonnet-Gajdos M, Turpin F, Bernard J (1972) Dysérythropoièse congénitale. Nouv Rev Fr Hematol 12:653–672

    CAS  PubMed  Google Scholar 

  19. Crookston JH, Crookston MC (1982) HEMPAS: clinical, hematological and serologic features. In: Salmon C (ed) Blood groups and other red cell markers in health and disease. Masson, New York, pp 29–38

  20. Crookston JH, Godwin TF, Wightmann KJR, Dacie JV, Lewis SM, Patterson M (1966) Congenital dyserythropoietic anemia (abstract). XIth Congress of the International Society of Hematology, Sydney

  21. Crookston JH, Crookston MC, Burnie KL, Francombe WH, Dacie JV, Davis JA, Lewis SM (1969) Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: a type of congenital dyserythropoietic anemia. Br J Haematol 17:11–26

    CAS  PubMed  Google Scholar 

  22. David G, VanDorpe A (1977) Aberrant congenital dyserythropoietic anemias. In: Lewis SM, Verwilghen RL (eds) Dyserythropoiesis. Academic, London, pp 92–102

  23. Delaunay J, Iolascon A (1999) The congenital dyserythropoietic anaemias. Baillieres Best Pract Res Clin Haematol 12:691–705

    Article  CAS  PubMed  Google Scholar 

  24. Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H, Eidelitz-Markus T, Kapelushnik J, Cattan D, Pariente A, Tulliez M, Cretien A, Schischmanoff PO, Iolascon A, Fibach E, Koren A, Rossler J, Le Merrer M, Yaniv I, Zaizov R, Ben Asher E, Olender T, Lancet D, Beckmann JS, Tamary H (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71:1467–1474

    Article  CAS  PubMed  Google Scholar 

  25. Eldor A, Matzner Y, Kahane I, Levene C, Polliack A (1978) Aberrant congenital dyserythropoietic anemia with negative acidified serum tests and features of thalassemia in a Kurdish family. Isr J Med Sci 14:1138–1143

    CAS  PubMed  Google Scholar 

  26. Enquist RW, Gockerman JP, Jenis EH, Warkel RL, Dillon DE (1972) Type II congenital dyserythropoietic anemia. Ann Intern Med 77:371–376

    CAS  PubMed  Google Scholar 

  27. Erdmann H, Heimpel H, Buchta H (1970) Positiver Säureserumtest und erhöhte Agglutinabilität durch Anti-i bei Patienten mit kongenitaler dyserythropoietischer Anämie. Klin Wochenschr 48:569–570

    CAS  PubMed  Google Scholar 

  28. Facon T, Mannessier L, Lepelly P, Weill J, Fenaux P, Dupriez B, Morel P, Jouet JP, Lepelley P (1990) Congenital dyserythropoietic anemia type I. Report on monozygotic twins with associated hemochromatosis and short stature. Blut 61:248–251

    CAS  PubMed  Google Scholar 

  29. Faille A, Najean Y, Dresch C (1972) Cinétique de l’érythropoièse dans 14 cas “d’érythropoièse inefficace” avec anomalies morphologiques des érythroblastes et polynucléarité. Nouv Rev Fr Hematol 12:631–652

    CAS  PubMed  Google Scholar 

  30. Fischer R, Tiemann CD, Engelhardt R, Nielsen P, Durken M, Gabbe EE, Janka GE (1999) Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol 60:289–299

    Article  CAS  PubMed  Google Scholar 

  31. Franchini M, Gandini G, Girelli D, Lippi G, de Gironcoli M, Aprili G (2001) Association of phlebotomy and subcutaneous bolus injection of deferoxamine for the treatment of anemic patients with iron overload. Haematologica 86:873–874

    CAS  PubMed  Google Scholar 

  32. Fukuda MN (1993) Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis. Ballieres Clin Haematol 6:493–511

    CAS  Google Scholar 

  33. Fukuda MN (1999) HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test. Biochim Biophys Acta 1455:231–239

    Article  CAS  PubMed  Google Scholar 

  34. Fukuda MN, Dell A, Scartezzini P (1987) Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II. J Biol Chem 262:7195–7206

    CAS  PubMed  Google Scholar 

  35. Gasser C (1981) Congenital-dyserythropoietic-malformation syndrome (abstract). 6th meeting of the International Society of Hematology, Athens

  36. Greiner TC, Burns CP, Dick FR, Henry KM, Mahmood I (1992) Congenital dyserythropoietic anemia type II diagnosed in a 69-year-old patient with iron overload. Am J Clin Pathol 98:522–525

    CAS  PubMed  Google Scholar 

  37. Heimpel H (1975) Dyserythropoiese und dyserythropoietische Anämien. Schweiz Med Wochenschr 105:1562–1568

    CAS  PubMed  Google Scholar 

  38. Heimpel H, Wendt F (1968) Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta 34:103–115

    CAS  PubMed  Google Scholar 

  39. Heimpel H, Wendt F, Klemm D, Schubothe H, Heilmeyer L (1968) Kongenitale dyserythropoietische Anämie. Dtsch Arch Klin Med 215:174–194

    CAS  Google Scholar 

  40. Heimpel H, Forteza-Vila J, Queisser W (1970) Morphological aberrations of the erythroblasts in congenital dyserythropoietic anemia type I and II (abstract). XIIIth International Congress of the International Society of Hematology, Munich, p 371

  41. Heimpel H, Forteza-Vila J, Queisser W, Spiertz E (1971) Electron and light microscopic study of the erythropoiesis of patients with congenital dyserythropoietic anemia. Blood 37:299–310

    CAS  PubMed  Google Scholar 

  42. Heimpel H, Maier K, Kohne E (1999) Kongenitale dyserythropoietische Anämien: Klinisches Bild und neue Erkenntnisse zu Epidemiologie, Pathogenese und Behandlung. Monatsschr Kinderheilkd 147:992–999

    Article  Google Scholar 

  43. Heimpel H, Eggl C, Griesshammer A, Maier K, Kohne E (2002) Splenectomy in congenital dyserythropoietic anemia (abstract). Egypt J Haematol 27 [Suppl 1]:83–84

    Google Scholar 

  44. Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M, Kohne E (2003) Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 102:4576–4581

    Article  CAS  PubMed  Google Scholar 

  45. Hodges VM, Molloy GY, Wickramasinghe SN (1999) Genetic heterogeneity of congenital dyserythropoietic anemia type I (letter). Blood 94:1139–1140

    CAS  PubMed  Google Scholar 

  46. Hofmann WK, Kaltwasser JP, Hoelzer D, Nielsen P, Gabbe EE (1997) Successful treatment of iron overload by phlebotomies in a patient with severe congenital dyserythropoietic anemia type II (letter). Blood 89:3068–3069

    CAS  PubMed  Google Scholar 

  47. Holmberg L, Jansson L, Rausing A, Henriksson P (1978) Type I congenital dyserythropoietic anaemia with myelopoietic abnormalities and hand malformations. Scand J Haematol 21:72–79

    CAS  PubMed  Google Scholar 

  48. Hovinga JA, Solenthaler M, Dufour JF (2003) Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two cases. Eur J Gastroenterol Hepatol 15:1141–1147

    Article  PubMed  Google Scholar 

  49. Iolascon A, D’Agostaro G, Perrotta S, Izzo P, Tavano R, Miraglia del Giudice B (1996) Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects. Haematologica 81:543–559

    CAS  PubMed  Google Scholar 

  50. Iolascon A, Miraglia del Giudice E, Perrotta S, Granatiero M, Zelante L, Gasparini P (1997) Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II). Blood 90:4197–4200

    CAS  PubMed  Google Scholar 

  51. Iolascon A, De Mattia D, Perrotta S, Carella M, Gasparini P, Lambertenghi Deliliers G (1998) Genetic heterogeneity of congenital dyserythropoietic anemia type II (letter). Blood 92:2593–2594

    CAS  PubMed  Google Scholar 

  52. Iolascon A, Servedio V, Carbone R, Totaro A, Carella M, Perrotta S, Wickramasinghe SN, Delaunay J, Heimpel H, Gasparini P (2000) Geographic distribution of CDA-II: did a founder effect operate in Southern Italy? Haematologica 85:470–474

    CAS  PubMed  Google Scholar 

  53. Iolascon A, Delaunay J, Wickramasinghe SN, Perrotta S, Gigante M, Camaschella C (2001) Natural history of congenital dyserythropoietic anemia type II. Blood 98:1258–1260

    Article  CAS  PubMed  Google Scholar 

  54. Iolascon A, Sabato V, De Mattia D, Locatelli F (2001) Bone marrow transplantation in a case of severe type II congenital dyserythropoietic anaemia (CDA II). Bone Marrow Transplant 27:213–215

    Article  CAS  PubMed  Google Scholar 

  55. Koenig E, Osieka R, Brittinger G (1973) Atypische kongenitale dyserythropoietische Anämie mit Thrombozytopenie. Verh Dtsch Ges Inn Med 79:490

    PubMed  Google Scholar 

  56. Krouwels FH, Bresser P, von dem Borne EKG (1999) Extramedullary hematopoisis: breath-taking and hair-raising. N Engl J Med 341:1702–1703

    Article  CAS  Google Scholar 

  57. Lavabre Bertrand T, Blanc P, Navarro R, Saghroun M, Vannereau H, Braun M, Wagner A, Taib J, Lavabre Bertrand C, Navarro M (1995) Alpha-interferon therapy for congenital dyserythropoiesis type I. Br J Haematol 89:929–932

    PubMed  Google Scholar 

  58. Le Merrer M, Girot R, Parent P, Cormier Daire V, Maroteaux P (1995) Acral dysostosis dyserythropoiesis syndrome. Eur J Pediatr 154:384–388

    Article  PubMed  Google Scholar 

  59. Lillicrap DP, Corbett WE, Giles AR, Ginsburg AD (1987) Erythroblast multinuclearity in bone marrow and spleen. Congenital dyserythropoietic anemia-like abnormalities without functional evidence of dyserythropoiesis. Arch Pathol Lab Med 111:536–539

    CAS  PubMed  Google Scholar 

  60. Lind L, Sandstroem H, Wahlin A, Eriksson M, Nilsson Sojka B, Sikstrom C, Holmgren G (1995) Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21–q25. Hum Mol Genet 4:109–112

    CAS  PubMed  Google Scholar 

  61. Marchetti M, Quaglini S, Barosi G (1998) Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios. J Intern Med 244:217–226

    Article  CAS  PubMed  Google Scholar 

  62. Marks PW, Mitus AJ (1996) Congenital dyserythropoietic anemias. Am J Hematol 51:55–63

    Article  CAS  PubMed  Google Scholar 

  63. Marwaha RK, Bansal D, Trehan A, Garewal G, Marwaha N (2003) Congenital dyserythropoietic anemia: clinical and hematological profile. Indian Pediatr 40:551–555

    CAS  PubMed  Google Scholar 

  64. McBride JA, Wilson WE, Baillie N (1971) Congenital dyserythropoietic anaemia—type IV (abstract). Blood 38:837

    Google Scholar 

  65. McCluggage WG, Hull D, Mayne E, Bharucha H, Wickramasinghe SN, Bharucha H (1996) Malignant lymphoma in congenital dyserythropoietic anemia type III. J Clin Pathol 49:509–602

    Google Scholar 

  66. Modell B (1977) Total management of thalassemia major. Arch Dis Child 52:489–500

    CAS  PubMed  Google Scholar 

  67. Nichols KE, Crispino JD, Poncz M, White JG, Orkin SH, Maris JM, Weiss MJ (2000) Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 24:266–270

    Article  CAS  PubMed  Google Scholar 

  68. Olivieri NF (1994) Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 331:574–578

    Article  CAS  PubMed  Google Scholar 

  69. Perrotta S, del Giudice EM, Carbone R, Servedio V, Schettini F Jr, Nobili B, Iolascon A (2000) Gilbert’s syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II). J Pediatr 136:556–559

    CAS  PubMed  Google Scholar 

  70. Pielage J, Stork T, Bunse I, Klambt C (2003) The Drosophila cell survival gene discs lost encodes a cytoplasmic Codanin-1-like protein, not a homolog of tight junction PDZ protein Patj. Dev Cell 5:841–851

    Article  CAS  PubMed  Google Scholar 

  71. Queisser W, Spiertz E, Jost E, Heimpel H (1971) Proliferation disturbances of erythroblasts in congenital dyserythropoietic anemia type I and II. Acta Haematol 45:65–76

    CAS  PubMed  Google Scholar 

  72. Remacha AF, Badell I, Pujol-Moix N, Parra J, Muniz-Diaz E, Ginovart G, Sarda MP, Hernandez A, Moliner E, Torrent M (2002) Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood 100:356–358

    Article  CAS  PubMed  Google Scholar 

  73. Rochant H, Gerbal A (1976) Polyagglutinabilité due à l’antigène Hempas. Rev Fr Transfus Immunohematol 19:239–245

    CAS  PubMed  Google Scholar 

  74. Roda L, Pasche J, Fournier A, Terorotua V, Wickramasinghe SN, Tamary H, Schischmanoff PO, Tchernia G, Delaunay J (2002) Congenital dyserythropoietic anemia, type 1, in a polynesian patient: response to interferon alpha2b. J Pediatr Hematol Oncol 24:503–506

    Article  PubMed  Google Scholar 

  75. Sabry MA, Zaki M, al Awadi SA, al Saleh Q, Mattar MS (1997) Non-haematological traits associated with congenital dyserythropoietic anaemia type 1: a new entity emerging. Clin Dysmorphol 6:205–212

    CAS  PubMed  Google Scholar 

  76. Sandstroem H, Wahlin A (2000) Congenital dyserythropoietic anemia type III. Haematologica 85:753–757

    PubMed  Google Scholar 

  77. Sandstroem H, Wahlin A, Eriksson M, Bergstrom I, Wickramasinghe SN (1994) Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III. Eur J Haematol 52:42–46

    PubMed  Google Scholar 

  78. Schatanek W, Hufnagl HD, Meiser RJ, Berberich R (1972) Kongenitale dyserythropoetische Anämie mit Eisenspeicherkrankheit. Muench Med Wochenschr 114:1933–1936

    CAS  Google Scholar 

  79. Schmidt U, Richter HJ, Samandari S (1987) Atypische kongenitale dyserythropoietische Anämie. Schweiz Med Wochenschr 117:1776–1780

    CAS  PubMed  Google Scholar 

  80. Seip M, Skrede S, Bjerve K, et al. (1982) A case of variant congenital dyserythropoietic anemia revisited. Scand J Haematol 28:278–280

    CAS  PubMed  Google Scholar 

  81. Shalev H, Kapleushnik Y, Haeskelzon L, Degani O, Kransnov T, Sphilberg O, Moser A, Yaniv I, Tamary H (2002) Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in young adults. Eur J Haematol 68:170–174

    Article  CAS  PubMed  Google Scholar 

  82. Shukry-Schulz S, Lawitschka A, Matthes S, Ebetsberger G, Heimpel H, Gadner H (2000) Congenital dyserythropoietic anemia—can peripheral stem cell transplantation be a therapeutic approach? Report of two cases (abstract). Hematol J 1 [Suppl 1]:44

    Google Scholar 

  83. Smithson WA, Perrault J (1982) Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I. Mayo Clin Proc 57:322–325

    CAS  PubMed  Google Scholar 

  84. Soysal T, Akun E, Ozaras R, Aki H, Ozturk M, Tuzuner N (2000) Congenital dyserythropoietic anemia type I with ringed sideroblasts. Haematologica (Budapest) 30:45–49

  85. Tamary H, Shalev H, Luria D, Shaft D, Zoldan M, Shalmon L, Gruinspan A, Stark B, Chaison M, Shinar E, Resnitzky P, Zaizov R (1996) Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood 87:1763–1770

    CAS  PubMed  Google Scholar 

  86. Tamary H, Shalmon L, Shalev H, Shaft D, Zoldan M, Resnitzky P, Korostishevky M, Zaizov R (1996) Localization of the gene for congenital dyserythropoietic anemia type I to chromosome 15q15.1.3 (abstract). Blood 88 [Suppl 1]:144

    Google Scholar 

  87. Tamary H, Shalmon L, Shalev H, Halil A, Dobrushin D, Ashkenazi N, Zoldan M, Resnitzky P, Korostishevsky M, Bonne Tamir B, Zaizov R (1998) Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1–15.3. Am J Hum Genet 62:1062–1069

    Article  CAS  PubMed  Google Scholar 

  88. Tamary H, Shalev H, Pinsk V, Zoldan M, Zaizov R (1999) No response to recombinant human erythropoietin therapy in patients with congenital dyserythropoietic anemia type I (abstract). Pediatr Hematol Oncol 16:165–168

    Article  CAS  PubMed  Google Scholar 

  89. Van Steenbergen W, Matthijs G, Roskams T, Fevery J (2002) Noniatrogenic haemochromatosis in congenital dyserythropoietic anaemia type II is not related to C282Y and H63D mutations in the HFE gene: report on two brothers. Acta Clin Belg 57:79–84

    PubMed  Google Scholar 

  90. Verwilghen RL (1976) Congenital dyserythropoietic anemia type II (Hempas). In: Porter R, Fitzsimons DW (eds) Congenital disorders of erythropoiesis. Ciba foundation symposium new series, 37. Elsevier, Amsterdam, pp 151–166

  91. Wendt F, Heimpel H (1967) Kongenitale dyserythropoetische Anämie bei einem eineiigen Zwillingspaar. Med Klinik 62:172–177

    CAS  Google Scholar 

  92. Wickramasinghe SN (1998) Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data. Blood Rev 12:178–200

    Article  CAS  PubMed  Google Scholar 

  93. Wickramasinghe SN, Pippard MJ (1986) Studies of erythroblast function in congenital dyserythropoietic anaemia, type I: evidence of impaired DNA, RNA, and protein synthesis and unbalanced globin chain synthesis in ultrastructurally abnormal cells. J Clin Pathol 39:881–890

    CAS  PubMed  Google Scholar 

  94. Wickramasinghe SN, Hasan R, Smythe J (1997) Reduced interferon-alpha production by Epstein-Barr virus transformed B-lymphoblastoid cell lines and lectin-stimulated lymphocytes in congenital dyserythropoietic anaemia type I. Br J Haematol 98:295–298

    Article  CAS  PubMed  Google Scholar 

  95. Wickramasinghe SN, Thein SL, Srichairatanakool S, Porter JB (1999) Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I. Br J Haematol 107:522–525

    Article  CAS  PubMed  Google Scholar 

  96. Wolff JA, Von Hofe H (1951) Familial erythroid multinuclearity. Blood 6:1274–1283

    CAS  PubMed  Google Scholar 

  97. Wong KY, Hug G, Lampkin BC (1972) Congenital dyserythropoetic anemia type II: ultrastructural and radioautographic studies of blood and bone marrow. Blood 39:23–30

    CAS  PubMed  Google Scholar 

  98. Zdebska E, Anselstetter V, Pacuszka T, Krauze R, Chelstowska A, Heimpel H, Koscielak J (1987) Glycolipids and glycopeptides of red cell membranes in congenital dyserthropoetic anemia type II (CDA II). Br J Haematol 66:385–391

    CAS  PubMed  Google Scholar 

  99. Zdebska E, Mendek-Czajkowska E, Ploski R, Wozniewicz B, Koscielak J (2002) Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers. Haematologica 87:126–130

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hermann Heimpel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heimpel, H. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis. Ann Hematol 83, 613–621 (2004). https://doi.org/10.1007/s00277-004-0892-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-004-0892-5

Keywords

Navigation